Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

222 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications.
Cronauer MV, Schulz WA, Seifert HH, Ackermann R, Burchardt M. Cronauer MV, et al. Among authors: schulz wa. Eur Urol. 2003 Mar;43(3):309-19. doi: 10.1016/s0302-2838(03)00005-8. Eur Urol. 2003. PMID: 12600436 Review.
Turnover of glutathione S-transferase alpha mRNAs is accelerated by 12-O-tetradecanoyl phorbol-13-acetate in human hepatoma and colon carcinoma cell lines.
Eickelmann P, Morel F, Schulz WA, Sies H. Eickelmann P, et al. Among authors: schulz wa. Eur J Biochem. 1995 Apr 1;229(1):21-6. doi: 10.1111/j.1432-1033.1995.0021l.x. Eur J Biochem. 1995. PMID: 7744032
P53 accumulation in precursor lesions and early stages of bladder cancer.
Schmitz-Dräger BJ, van Roeyen CR, Grimm MO, Gerharz CD, Decken K, Schulz WA, Bültel H, Makri D, Ebert T, Ackermann R. Schmitz-Dräger BJ, et al. Among authors: schulz wa. World J Urol. 1994;12(2):79-83. doi: 10.1007/BF00184241. World J Urol. 1994. PMID: 8087143
c-myc in bladder cancer. Clinical findings and analysis of mechanism.
Schmitz-Dräger BJ, Schulz WA, Jürgens B, Gerharz CD, van Roeyen CR, Bültel H, Ebert T, Ackermann R. Schmitz-Dräger BJ, et al. Among authors: schulz wa. Urol Res. 1997;25 Suppl 1:S45-9. doi: 10.1007/BF00942047. Urol Res. 1997. PMID: 9079756
Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies.
Schulz WA, Krummeck A, Rösinger I, Eickelmann P, Neuhaus C, Ebert T, Schmitz-Dräger BJ, Sies H. Schulz WA, et al. Pharmacogenetics. 1997 Jun;7(3):235-9. doi: 10.1097/00008571-199706000-00008. Pharmacogenetics. 1997. PMID: 9241663
p53 and MDM2 in the development and progression of bladder cancer.
Schmitz-Dräger BJ, Kushima M, Goebell P, Jax TW, Gerharz CD, Bültel H, Schulz WA, Ebert T, Ackermann R. Schmitz-Dräger BJ, et al. Among authors: schulz wa. Eur Urol. 1997;32(4):487-93. Eur Urol. 1997. PMID: 9412812
DNA methylation in urological malignancies (review).
Schulz WA. Schulz WA. Int J Oncol. 1998 Jul;13(1):151-67. Int J Oncol. 1998. PMID: 9625817 Review.
Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosis.
Anastasiadis AG, Lemm I, Radzewitz A, Lingott A, Ebert T, Ackermann R, Ryffel GU, Schulz WA. Anastasiadis AG, et al. Among authors: schulz wa. Anticancer Res. 1999 May-Jun;19(3A):2105-10. Anticancer Res. 1999. PMID: 10470156
Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
Franke KH, Miklosi M, Goebell P, Clasen S, Steinhoff C, Anastasiadis AG, Gerharz C, Schulz WA. Franke KH, et al. Among authors: schulz wa. Urology. 2000 Oct 1;56(4):689-95. doi: 10.1016/s0090-4295(00)00678-6. Urology. 2000. PMID: 11018640
Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinoma.
Santourlidis S, Warskulat U, Florl AR, Maas S, Pulte T, Fischer J, Müller W, Schulz WA. Santourlidis S, et al. Among authors: schulz wa. Mol Carcinog. 2001 Sep;32(1):36-43. doi: 10.1002/mc.1062. Mol Carcinog. 2001. PMID: 11568974
222 results
Jump to page